PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FMS vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FMS and SPY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

FMS vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fresenius Medical Care AG & Co. KGaA (FMS) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%NovemberDecember2025FebruaryMarchApril
224.08%
1,165.47%
FMS
SPY

Key characteristics

Sharpe Ratio

FMS:

1.04

SPY:

0.30

Sortino Ratio

FMS:

1.52

SPY:

0.56

Omega Ratio

FMS:

1.19

SPY:

1.08

Calmar Ratio

FMS:

0.49

SPY:

0.31

Martin Ratio

FMS:

4.24

SPY:

1.40

Ulcer Index

FMS:

7.27%

SPY:

4.18%

Daily Std Dev

FMS:

29.76%

SPY:

19.64%

Max Drawdown

FMS:

-77.28%

SPY:

-55.19%

Current Drawdown

FMS:

-52.43%

SPY:

-13.86%

Returns By Period

In the year-to-date period, FMS achieves a 4.46% return, which is significantly higher than SPY's -9.91% return. Over the past 10 years, FMS has underperformed SPY with an annualized return of -4.17%, while SPY has yielded a comparatively higher 11.59% annualized return.


FMS

YTD

4.46%

1M

-4.56%

6M

15.37%

1Y

25.53%

5Y*

-5.64%

10Y*

-4.17%

SPY

YTD

-9.91%

1M

-6.90%

6M

-9.38%

1Y

6.72%

5Y*

14.62%

10Y*

11.59%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FMS vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FMS
The Risk-Adjusted Performance Rank of FMS is 8080
Overall Rank
The Sharpe Ratio Rank of FMS is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of FMS is 8080
Sortino Ratio Rank
The Omega Ratio Rank of FMS is 7777
Omega Ratio Rank
The Calmar Ratio Rank of FMS is 7474
Calmar Ratio Rank
The Martin Ratio Rank of FMS is 8585
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 5757
Overall Rank
The Sharpe Ratio Rank of SPY is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 5555
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 5757
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 5959
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FMS vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fresenius Medical Care AG & Co. KGaA (FMS) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FMS, currently valued at 1.04, compared to the broader market-2.00-1.000.001.002.003.00
FMS: 1.04
SPY: 0.30
The chart of Sortino ratio for FMS, currently valued at 1.52, compared to the broader market-6.00-4.00-2.000.002.004.00
FMS: 1.52
SPY: 0.56
The chart of Omega ratio for FMS, currently valued at 1.19, compared to the broader market0.501.001.502.00
FMS: 1.19
SPY: 1.08
The chart of Calmar ratio for FMS, currently valued at 0.49, compared to the broader market0.001.002.003.004.00
FMS: 0.49
SPY: 0.31
The chart of Martin ratio for FMS, currently valued at 4.24, compared to the broader market-5.000.005.0010.0015.0020.00
FMS: 4.24
SPY: 1.40

The current FMS Sharpe Ratio is 1.04, which is higher than the SPY Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of FMS and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.04
0.30
FMS
SPY

Dividends

FMS vs. SPY - Dividend Comparison

FMS's dividend yield for the trailing twelve months is around 2.68%, more than SPY's 1.36% yield.


TTM20242023202220212020201920182017201620152014
FMS
Fresenius Medical Care AG & Co. KGaA
2.68%2.80%2.97%4.34%2.57%1.70%1.78%1.95%0.98%1.04%1.05%1.44%
SPY
SPDR S&P 500 ETF
1.36%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

FMS vs. SPY - Drawdown Comparison

The maximum FMS drawdown since its inception was -77.28%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for FMS and SPY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-52.43%
-13.86%
FMS
SPY

Volatility

FMS vs. SPY - Volatility Comparison

The current volatility for Fresenius Medical Care AG & Co. KGaA (FMS) is 11.87%, while SPDR S&P 500 ETF (SPY) has a volatility of 14.52%. This indicates that FMS experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
11.87%
14.52%
FMS
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab